$AMGN News

Amgen (AMGN) Gets A Fresh Target, Is It Fully Priced?

Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $457

Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

Amgen Stock Surges 3.5% as Healthcare Hits Record High

Argus Research Maintains Buy on Amgen, Raises Price Target to $460

Mizuho Maintains Neutral on Amgen, Raises Price Target to $352

Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $400

Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $380

Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions

AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD

Reported Earlier, Amgen To Open New Science And Innovation Center At Genome Valley In Hyderabad

Amgen (AMGN) Q2 2026 Earnings Call Transcript

$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

Guggenheim Maintains Neutral on Amgen, Raises Price Target to $388

Amgen (AMGN) Stock Sees Fair Value Lift After Q2 Beat And Analyst Target Hikes

Citigroup Maintains Neutral on Amgen, Raises Price Target to $405

Bernstein Maintains Market Perform on Amgen, Raises Price Target to $345

Amgen Stock Climbs as Drug Growth Outruns Obesity Setback

Amgen gains after strong quarterly results and continued product momentum

UBS Maintains Buy on Amgen, Raises Price Target to $440